Study on pathogenic bacteria distribution and antimicrobial resistance in adult urinary tract infections in a tertiary hospital in Southern Jiangxi, China, 2021-2024
Abstract
Background: Urinary tract infections (UTIs) are common global bacterial infections. Rising antimicrobial resistance complicates their treatment. Analyzing pathogen distribution and resistance patterns in southern Jiangxi, China, is crucial for informing empirical treatment and infection management.
Methods: We conducted a retrospective study of 3,212 urinary isolates from adult UTI patients at our hospital from January 2021 to December 2024. We used WHONET 5.6 software to analyze the distribution of pathogens and antimicrobial resistance patterns, and compared these patterns across different years, age groups, genders, and wards using the χ² test.
Results: Gram-negative bacteria predominated (75.37%). Escherichia coli was the most prevalent at 49.00%, with Klebsiella pneumoniae following at 9.34%. Carbapenem-resistant Klebsiella pneumoniae (CRKP) increased significantly. Its resistance to imipenem rose from 4.2% in 2021 to 24.5% in 2024. Vancomycin-resistant Enterococcus faecium (VREfm) emerged, reaching 9.4% in 2024. CRKP resistance was highest in Intensive Care Units (ICUs) (30.8%), compared with other clinical departments.
Conclusion: This study systematically analyzes the dynamic changes in pathogen profiles and antimicrobial resistance of adult urinary tract infections in southern Jiangxi from 2021 to 2024. It highlights the concurrent, rapid rise of CRKP and VREfm. The findings show a serious threat from multidrug-resistant bacteria, urging targeted infection control…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.